Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin?

Clinical Infectious Diseases

Volumn 27, Issue 6, 1998, Pages 1401-1405

  Shafran, Stephen D ^a   Talbot, James A ^b   Chomyc, Sylvia ^b   Davison, Estelle ^b   Singer, Joel ^b   Phillips, Peter ^b   Salit, Irving ^b   Walmsley, Sharon L ^b   Fong, Ignatius W ^b   Gill, M John ^b   Rachlis, Anita R ^b   Lalonde, Richard G ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; RIFABUTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; MYCOBACTERIUM INTRACELLULARE AVIUM; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0032458946     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515022     Document Type: Article

References (15)

1. Bass JB Jr, Farer LS, Hopewell PC, et al. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149:1359-74.
2. Chaisson RE, Benson CA, Dube MP, et al. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease: a randomized double-blind, dose-ranging study in patients with AIDS. Ann Intern Med 1994; 121:905-11.
3. Heifets L, Mor N, Vanderkolk J. Mycobacterium avium strains resistant to clarithromycin and azithromycin. Antimicrob Agents Chemother 1993; 37:2364-70.
4. Shafran SD, Singer J, Zarowny DP, et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. N Engl J Med 1996; 335:377-83.
5. Shafran SD, Deschěnes J, Miller M, Phillips P, Toma E. Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. N Engl J Med 1994; 330:438-9.
6. Heifets L, Lindholm-Levy P, Libonati J, et al. Radiometric broth macrodilution method for determination of MIC with M. avium complex. Proposed guidelines. Denver: National Jewish Center for Immunology and Respiratory Medicine, 1993.
7. Heifets LB, Lindholm-Levy PJ, Comstock RD. Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. Am Rev Respir Dis 1992; 145:856-8.
8. Dubé MP, Sattler FR, Torriani FJ, et al. A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. J Infect Dis 1997; 176:1225-32.
9. Siddiqi SH, Heifets LB, Cynamon MH, et al. Rapid broth microdilution methods for determination of MICs for Mycobacterium avium isolates. J Clin Microbiol 1993; 31:2332-8.
10. Heifets LB, Iseman MD, Lindholm-Levy PJ. Bacteriostatic and bacteriocidal effects of rifabutin (ansamycin LM 427) on Mycobacterium avium clinical isolates. In: Casal M, ed. Mycobacteria of clinical interest. Amsterdam: Elsevier Science, 1986:180-3.
11. Horsburgh CR Jr, Mason UG III, Heifets LB, et al. Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing. Am Rev Respir Dis 1987; 135:418-21.
12. Tsukamura M. Evidence that antituberculosis drugs are really effective in the treatment of pulmonary infection caused by Mycobacterium avium complex. Am Rev Respir Dis 1988; 137:144-8.
13. Gordon SM, Horsburgh CR Jr, Peloquin CA, et al. Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease. J Infect Dis 1993; 168:1559-62.
14. Sison JP, Yao Y, Kemper CA, et al. Treatment of Mycobacterium avium complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans? J Infect Dis 1996; 173:677-83.
15. Phillips P, Bassiri A, Singer J, B-Kwiatkowski M, Black W, Montaner J. Disseminated M. avium complex (DMAC) infection and AIDS: correlation of treatment regimen, in vitro susceptibilities, and survival [abstract Th.B.4304]. In: Program and abstracts of the XI International Conference on AIDS (Vancouver).Vancouver: XI International Conference on AIDS Society, 1996.